Skip to content

Ivím Health review

Sells compounded semaglutide and tirzepatide in prepaid programs, plus brand-name drugs such as the Wegovy pill with insurance help. The catch: an open FDA warning letter from February 2026, and compounded programs cannot be cancelled.

Research-based review: nobody from GLPLens signed up, paid or received medication. Everything below comes from Ivím Health's own pages and FDA, read Sep 28, 2026. How we score.

44 / 100

What it prescribes
0 / 40 FDA warning letter about GLP-1 products (2026-02-20), not resolved
Published prices
20 / 20 Membership and medication prices published
Commitment
12 / 20 Commitment of 3 months or less
Insurance
10 / 10 Says insurance can pay for the medication
Where it operates
2 / 10 States not stated

Website: ivimhealth.com. We do not link to it: it has an FDA warning letter about GLP-1 products. Brand-name options: the price table.

Good

  • Offers brand-name GLP-1s, with an insurance team for coverage checks
  • Wegovy pill priced at the maker's own cash prices
  • Publishes compounded program prices and its membership fee

Watch out for

  • FDA warning letter about its compounded GLP-1 marketing, not closed out
  • Compounded programs run for a fixed term and cannot be cancelled once started
  • Membership fee is charged on top of every medicine
  • Medicines are non-refundable
  • No list of the states it serves

What it is

Ivím Health (Ivim Services LLC) is a telehealth company for weight loss and hormone health. It sells compounded semaglutide and tirzepatide in fixed-length programs, and it also prescribes brand-name GLP-1s with help from an insurance team. FDA sent it a warning letter in February 2026 about how it marketed the compounded drugs [16].

What it prescribes

Both kinds. The compounded options are semaglutide and tirzepatide [1]. FDA does not review compounded drugs for safety, effectiveness or quality before they are sold [18], and a compounded injection is a different product from a brand-name pen. Ivim’s own terms warn that if compounded semaglutide or tirzepatide become unavailable, for example after a change in FDA compounding policy, members may be moved to another program [15].

The brand-name side includes the Wegovy pill, Wegovy, Zepbound and Foundayo. Ivim says it helps patients check insurance coverage or choose self-pay [13].

What it costs

Every option adds a monthly fee for Ivim’s care: the Wegovy pill page calls it a $75 membership [9], and the compounded page calls it a $74.99 program fee [1]. The compounded programs are advertised from $75 a month for semaglutide and $133 a month for tirzepatide, before that fee [1]. The homepage labels those prices as 6-month programs [2], and we found no per-month price for shorter ones, so confirm the total at checkout.

The Wegovy pill starts at $149 a month for the 1.5 mg dose, at prices Ivim says are set by Novo Nordisk, with the membership billed separately [8] [9]. That matches NovoCare’s own prices of $149, $199 and $299 by dose [10].

Insurance can pay for some brand-name drugs. Ivim says many plans cover the Wegovy pill and that its team verifies coverage and handles the paperwork [11], naming Cigna, Aetna, United Healthcare and Blue Cross Blue Shield among the insurers it works with [12]. If a prior authorization is denied, the membership fee is not refunded [14]. Our prior authorization guide explains the process.

Signing up and cancelling

The compounded programs run for a term you pick at checkout: 1, 2, 4 or 6 months [4]. Ivim says most patients start with a 4-month option [3], and that cancellation is not available once a program has started [5]. Its terms describe a partial refund of unshipped medicine on 4- or 6-month plans, minus fees of $50 to $100 per unused portion [6]. The two pages do not line up, so get the cancellation terms in writing. Prescribed medicines are non-refundable [7]. See our cancellation guide.

Safety and regulatory record

FDA reviewed Ivim’s website in December 2025 and found it offered compounded semaglutide and tirzepatide [16]. The February 2026 warning letter said the product photos showed “Ivim” on the label, suggesting Ivim made the drugs when it did not [17]. FDA’s database listed no close-out letter when this page was updated, so we treat the letter as open.

Because of the letter, and because it sells compounded drugs, GLPLens does not link to Ivim.

Who it suits, and who should look elsewhere

Ivim may suit someone with commercial insurance who wants help getting the Wegovy pill or another brand-name GLP-1 covered and does not mind a monthly membership. Look elsewhere if an open FDA warning letter concerns you, or if you want to be able to stop a compounded program partway through. Our programs page compares brand-name services.

Sources

  1. Compounded Semaglutide (GLP-1) starting at* $75 /mo Compounded Tirzepatide (GLP-1 + GIP) starting at* $133 /mo + $74.99/mo Program Fee ivimhealth.com, read Sep 28, 2026.
  2. 6 months of compounded Tirzepatide $133 per month 6 months of compounded Semaglutide $75 per month ivimhealth.com, read Sep 28, 2026.
  3. Our GLP-1 ID programs are structured based on the duration you select at checkout. Most patients begin with the Jumpstart option, which is a 4-month commitment. ivimhealth.com, read Sep 28, 2026.
  4. You can choose from 1, 2, 4, or 6-month programs, and your access to care, medication, and support will remain active for the full duration you select. ivimhealth.com, read Sep 28, 2026.
  5. Because GLP-1 medications are prescribed and shipped based on your selected program length, cancellation is not available once your program has started. ivimhealth.com, read Sep 28, 2026.
  6. Upon cancellation, we will refund any unshipped medication, less an administrative/restocking fee of $100 for each undeveloped three-month portion of your plan or $50 for each undeveloped two-month portion (as applies to four- or six-month programs). ivimhealth.com, read Sep 28, 2026.
  7. Refunds. All prescribed medications are non-refundable, regardless of usage, program duration, or cancellation of membership. ivimhealth.com, read Sep 28, 2026.
  8. Start with 1.5mg — $149/mo ivimhealth.com, read Sep 28, 2026.
  9. Pricing set by Novo Nordisk. Ivím membership ($75/mo) required for clinical support and is billed separately. ivimhealth.com, read Sep 28, 2026.
  10. Patients pay $149 for each month of 1.5 mg, $199 per month for 4 mg, and $299 per month for 9 mg and 25 mg. novocare.com, read Sep 28, 2026.
  11. Many insurance plans cover the Wegovy® Pill. Our dedicated insurance team will verify your coverage, handle the paperwork, and find you the lowest possible copay — before you pay anything. ivimhealth.com, read Sep 28, 2026.
  12. Insurance companies we work with include Cigna, Aetna, United Healthcare and Blue Cross Blue Shield. ivimhealth.com, read Sep 28, 2026.
  13. Coverage depends on your insurance plan and whether Zepbound® is prescribed for an FDA-approved use. Ivím Health offers a free initial consultation to navigate insurance or explore self-pay options. ivimhealth.com, read Sep 28, 2026.
  14. If a prior authorization is denied or delayed, or if any service, test, treatment, medication, or order is not covered by insurance or another third party for reasons beyond Ivim’s control, the membership fee will not be refunded. ivimhealth.com, read Sep 28, 2026.
  15. If compounded semaglutide or compounded tirzepatide become unavailable for any reason, including changes in FDA compounding policy or pharmacy availability, Ivim will notify enrolled members and make reasonable efforts to facilitate continuity of care, which may include transition to an alternative program. ivimhealth.com, read Sep 28, 2026.
  16. This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website content at the internet address https://www.ivimhealth.com, in December 2025, and has observed that your website offers compounded drug products, including semaglutide and tirzepatide drug products. fda.gov, read Sep 28, 2026.
  17. The compounded semaglutide and tirzepatide products displayed on your website identify “Ivim” on the pictured label, suggesting Ivim is the compounder of those drugs when in fact it is not. fda.gov, read Sep 28, 2026.
  18. However, compounded drugs are not FDA approved. This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed. fda.gov, read Sep 28, 2026.

Other reviews: all programs, scored the same way. Real users' experiences: reader stories.